BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Petrone L, Vanini V, Chiacchio T, Petruccioli E, Cuzzi G, Schininà V, Palmieri F, Ippolito G, Goletti D. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection. Tuberculosis (Edinb) 2018;111:147-53. [PMID: 30029901 DOI: 10.1016/j.tube.2018.06.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Migliori GB, Ong CWM, Petrone L, D'Ambrosio L, Centis R, Goletti D. The definition of tuberculosis infection based on the spectrum of tuberculosis disease. Breathe (Sheff) 2021;17:210079. [PMID: 35035549 DOI: 10.1183/20734735.0079-2021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Alvarez AH. Revisiting tuberculosis screening: An insight to complementary diagnosis and prospective molecular approaches for the recognition of the dormant TB infection in human and cattle hosts. Microbiol Res 2021;252:126853. [PMID: 34536677 DOI: 10.1016/j.micres.2021.126853] [Reference Citation Analysis]
3 Jafrasteh A, Karimi A, Hoseinialfatemi SM, Azimi L, Tabarsi P, Nasehi M, Naseri M, Panahi Mishkar A, Sheikhi M, Mansour Ghanaie R. Evaluation of Interleukin-2 to Detect Active and Latent Tuberculosis among Household Contacts of Pulmonary Tuberculosis Cases. Arch Pediatr Infect Dis 2021;9. [DOI: 10.5812/pedinfect.109398] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Petruccioli E, Najafi Fard S, Navarra A, Petrone L, Vanini V, Cuzzi G, Gualano G, Pierelli L, Bertoletti A, Nicastri E, Palmieri F, Ippolito G, Goletti D. Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection. J Transl Med 2021;19:272. [PMID: 34174875 DOI: 10.1186/s12967-021-02938-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Suzukawa M, Takeda K, Akashi S, Asari I, Kawashima M, Ohshima N, Inoue E, Sato R, Shimada M, Suzuki J, Yamane A, Tamura A, Ohta K, Tohma S, Teruya K, Nagai H. Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis. J Infect 2020;80:547-53. [PMID: 32092390 DOI: 10.1016/j.jinf.2020.02.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wei Z, Li Y, Wei C, Li Y, Xu H, Wu Y, Jia Y, Guo R, Jia J, Qi X, Li Z, Gao X. The meta-analysis for ideal cytokines to distinguish the latent and active TB infection. BMC Pulm Med 2020;20:248. [PMID: 32948170 DOI: 10.1186/s12890-020-01280-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Morgan J, Muskat K, Tippalagama R, Sette A, Burel J, Lindestam Arlehamn CS. Classical CD4 T cells as the cornerstone of antimycobacterial immunity. Immunol Rev 2021;301:10-29. [PMID: 33751597 DOI: 10.1111/imr.12963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Meier NR, Sutter TM, Jacobsen M, Ottenhoff THM, Vogt JE, Ritz N. Machine Learning Algorithms Evaluate Immune Response to Novel Mycobacterium tuberculosis Antigens for Diagnosis of Tuberculosis. Front Cell Infect Microbiol 2020;10:594030. [PMID: 33489933 DOI: 10.3389/fcimb.2020.594030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chiacchio T, Petruccioli E, Vanini V, Cuzzi G, Massafra U, Baldi G, Navarra A, Scrivo R, Mastroianni C, Sauzullo I, Esposito C, Palmieri F, Cantini F, Goletti D. Characterization of QuantiFERON-TB-Plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseases. J Infect 2019;79:15-23. [PMID: 30981891 DOI: 10.1016/j.jinf.2019.04.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
10 Park JY, Park SB, Park H, Kim J, Kim YN, Kim S. Cytokine and Chemokine mRNA Expressions after Mycobacterium tuberculosis-Specific Antigen Stimulation in Whole Blood from Hemodialysis Patients with Latent Tuberculosis Infection. Diagnostics (Basel) 2021;11:595. [PMID: 33810426 DOI: 10.3390/diagnostics11040595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Petrone L, Bondet V, Vanini V, Cuzzi G, Palmieri F, Palucci I, Delogu G, Ciccosanti F, Fimia GM, Blauenfeldt T, Ruhwald M, Duffy D, Goletti D. First description of agonist and antagonist IP-10 in urine of patients with active TB. Int J Infect Dis 2019;78:15-21. [PMID: 30201505 DOI: 10.1016/j.ijid.2018.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
12 Sudbury EL, Clifford V, Messina NL, Song R, Curtis N. Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review. J Infect 2020;81:873-81. [PMID: 33007340 DOI: 10.1016/j.jinf.2020.09.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
13 Qiu X, Tang Y, Zou R, Zeng Y, Yue Y, Li W, Qu Y, Mu D. Diagnostic accuracy of interferon-gamma-induced protein 10 for differentiating active tuberculosis from latent tuberculosis: A meta-analysis. Sci Rep 2019;9:11408. [PMID: 31388072 DOI: 10.1038/s41598-019-47923-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
14 Pan L, Huang M, Jia H, Deng G, Chen Y, Wei R, Zhang M, Li X, Sun Q, Fang M, Ren P, Xing A, Chen Q, Li X, Du B, Chen T, Gao M, Zhang Z. Diagnostic Performance of a Novel CXCL10 mRNA Release Assay for Mycobacterium tuberculosis Infection. Front Microbiol 2022;13:825413. [PMID: 35432271 DOI: 10.3389/fmicb.2022.825413] [Reference Citation Analysis]
15 Hong JY, Park SY, Kim A, Cho SN, Hur YG. Comparison of QFT-Plus and QFT-GIT tests for diagnosis of M. tuberculosis infection in immunocompetent Korean subjects. J Thorac Dis 2019;11:5210-7. [PMID: 32030238 DOI: 10.21037/jtd.2019.12.11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
16 Sivakumaran D, Jenum S, Ritz C, Vaz M, Doherty TM, Grewal HMS. Improving Assignments for Therapeutic and Prophylactic Treatment Within TB Households. A Potential for Immuno-Diagnosis? Front Immunol 2022;13:801616. [DOI: 10.3389/fimmu.2022.801616] [Reference Citation Analysis]
17 Bai KJ, Tung NT, Hsiao TC, Chen TL, Chung KF, Ho SC, Tsai CY, Chen JK, Lee CN, Lee KY, Chang CC, Chen TT, Feng PH, Chen KY, Su CL, Thao HNX, Dung HB, Thuy TPC, Lee YL, Chuang HC. Associations between lung-deposited dose of particulate matter and culture-positive pulmonary tuberculosis pleurisy. Environ Sci Pollut Res Int 2021. [PMID: 34448140 DOI: 10.1007/s11356-021-16008-5] [Reference Citation Analysis]
18 Viana Machado F, Morais C, Santos S, Reis R. Evaluation of CD8+ response in QuantiFERON-TB Gold Plus as a marker of recent infection. Respir Med 2021;185:106508. [PMID: 34171790 DOI: 10.1016/j.rmed.2021.106508] [Reference Citation Analysis]
19 Halliday A, Masonou T, Tolosa-wright M, Mandagere V, Lalvani A. Immunodiagnosis of active tuberculosis. Expert Review of Respiratory Medicine 2019;13:521-32. [DOI: 10.1080/17476348.2019.1615888] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 Bayaa R, Ndiaye MDB, Chedid C, Kokhreidze E, Tukvadze N, Banu S, Uddin MKM, Biswas S, Nasrin R, Ranaivomanana P, Raherinandrasana AH, Rakotonirina J, Rasolofo V, Delogu G, De Maio F, Goletti D, Endtz H, Ader F, Hamze M, Ismail MB, Pouzol S, Rakotosamimanana N, Hoffmann J; HINTT working group within the GABRIEL network. Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring. Sci Rep 2021;11:13646. [PMID: 34211042 DOI: 10.1038/s41598-021-93059-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Ocaña-Guzmán R, Téllez-Navarrete NA, Ramón-Luing LA, Herrera I, De Ita M, Carrillo-Alduenda JL, Choreño-Parra JA, Medina-Quero K, Zúñiga J, Chávez-Galán L. Leukocytes from Patients with Drug-Sensitive and Multidrug-Resistant Tuberculosis Exhibit Distinctive Profiles of Chemokine Receptor Expression and Migration Capacity. J Immunol Res 2021;2021:6654220. [PMID: 33977111 DOI: 10.1155/2021/6654220] [Reference Citation Analysis]
22 Ghanaie RM, Karimi A, Azimi L, James S, Nasehi M, Mishkar AP, Sheikhi M, Fallah F, Tabatabaei SR, Hoseini-Alfatemi SM. Diagnosis of latent tuberculosis infection among pediatric household contacts of Iranian tuberculosis cases using tuberculin skin test, IFN- γ release assay and IFN-γ-induced protein-10. BMC Pediatr 2021;21:76. [PMID: 33573613 DOI: 10.1186/s12887-021-02524-3] [Reference Citation Analysis]
23 Petrone L, Tamarozzi F, Vola A, Gomez Morales MA, Ludovisi A, Najafi Fard S, Mariconti M, Brunetti E, Goletti D. Accuracy of an experimental whole-blood test for detecting reactivation of echinococcal cysts. PLoS Negl Trop Dis 2021;15:e0009648. [PMID: 34415898 DOI: 10.1371/journal.pntd.0009648] [Reference Citation Analysis]
24 Krishnan S, Queiroz ATL, Gupta A, Gupte N, Bisson GP, Kumwenda J, Naidoo K, Mohapi L, Mave V, Mngqibisa R, Lama JR, Hosseinipour MC, Andrade BB, Karakousis PC. Integrative Multi-Omics Reveals Serum Markers of Tuberculosis in Advanced HIV. Front Immunol 2021;12:676980. [PMID: 34168648 DOI: 10.3389/fimmu.2021.676980] [Reference Citation Analysis]
25 Can S, Sahin A, Dalgic N, Aygün D. The Diagnostic Value of Blood and Urine IP-10 Test in Children Having Active Tuberculosis or Latent Tuberculosis Infection. Journal of Pediatric Infectious Diseases 2021;16:216-22. [DOI: 10.1055/s-0041-1731039] [Reference Citation Analysis]
26 Palucci I, Battah B, Salustri A, De Maio F, Petrone L, Ciccosanti F, Sali M, Bondet V, Duffy D, Fimia GM, Goletti D, Delogu G. IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assay. Int J Med Microbiol 2019;309:299-306. [PMID: 31147175 DOI: 10.1016/j.ijmm.2019.05.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
27 Manngo PM, Gutschmidt A, Snyders CI, Mutavhatsindi H, Manyelo CM, Makhoba NS, Ahlers P, Hiemstra A, Stanley K, McAnda S, Kidd M, Malherbe ST, Walzl G, Chegou NN. Prospective evaluation of host biomarkers other than interferon gamma in QuantiFERON Plus supernatants as candidates for the diagnosis of tuberculosis in symptomatic individuals. J Infect 2019;79:228-35. [PMID: 31319143 DOI: 10.1016/j.jinf.2019.07.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
28 Petruccioli E, Chiacchio T, Navarra A, Vanini V, Cuzzi G, Cimaglia C, Codecasa LR, Pinnetti C, Riccardi N, Palmieri F, Antinori A, Goletti D. Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection. J Infect 2020;80:536-46. [PMID: 32097688 DOI: 10.1016/j.jinf.2020.02.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
29 Yang Q, Chen Q, Zhang M, Cai Y, Yang F, Zhang J, Deng G, Ye T, Deng Q, Li G, Zhang H, Yi Y, Huang RP, Chen X. Identification of eight-protein biosignature for diagnosis of tuberculosis. Thorax 2020;75:576-83. [PMID: 32201389 DOI: 10.1136/thoraxjnl-2018-213021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]